A Cure in Sight (EIN 461274306) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

Melody King

Phone

9194134081

Tax Period

2023-01-01 to 2023-12-31

A Cure in Sight, founded in 2014, is a small nonprofit in the Medical Research sector that reported $409K in total revenue in fiscal year 2023. Revenue fell 36% from the prior year — a significant decline worth monitoring. Expenses of $491K exceeded revenue, resulting in a 20% operating deficit.

Mission

A Cure in Sight's mission is to provide funding for patient services for ocular melanoma eye cancer patients education awareness and research.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $320,038

Program Service Revenue $0

Investment Income $0

Other Revenue $88,512

TOTAL REVENUE $408,550

Expense Breakdown

Grants Paid $177,018

Salaries & Benefits $47,052

Fundraising Expenses $11,932

Program Expenses $298,435

Other Expenses $267,258

TOTAL EXPENSES $491,328

Year-over-Year Comparison

	2023	2022	Change
Revenue	$408,550	$641,566	-0.4%
Expenses	$491,328	$451,572	+0.1%
Net Income	$-82,778	$189,994	-1.4%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Melody King	President	10.00	Officer	$0	$0	$0
Suzanne Luscure	Secretary	5.00	Officer	$0	$0	$0
Marlene Day	Treasurer	5.00	Officer	$0	$0	$0
Loren Seaman	Vice President	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$408,550	$491,328	$197,429	$-82,778
2022	$641,566	$451,572	$280,207	$189,994
2021	$324,456	$286,477	$90,213	$37,979
2021	$324,456	$286,477	$90,213	$37,979
2020	$276,921	$239,804	$52,234	$37,117
2019	$220,231	$278,125	$15,117	$-57,894
2018	$124,109	$115,337	$205,727	$8,772

A Cure in Sight